As the unexpected increased risk of mortality at term observed in the GDM group might be due to undiagnosed pregestational diabetes in this group, we repeated the analyses using more restrictive criteria to exclude women classified as having GDM but to whom insulin or oral glucose-lowering agents were dispensed at least once during the year after pregnancy. The gene discussed is INS; the disease is gestational diabetes.